GERM vs. MDEV
GERM (Amplify Treatments, Testing and Advancements ETF) and MDEV (First Trust Indxx Medical Devices ETF) are both Health & Biotech Equities funds - GERM tracks the Prime Treatments, Testing and Advancements Index while MDEV tracks the Indxx Global Medical Equipment Index. Both are passively managed. Over the past year, GERM returned 0.00% vs -7.05% for MDEV. GERM charges 0.68%/yr vs 0.70%/yr for MDEV.
Performance
GERM vs. MDEV - Performance Comparison
Loading charts...
Returns By Period
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
MDEV
- 1D
- 0.04%
- 1M
- 1.54%
- YTD
- -11.48%
- 6M
- -12.29%
- 1Y
- -7.05%
- 3Y*
- -2.86%
- 5Y*
- —
- 10Y*
- —
GERM vs. MDEV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% |
MDEV First Trust Indxx Medical Devices ETF | -11.48% | 2.00% | -3.12% |
GERM vs. MDEV - Sectors Allocation Comparison
Sectors
GERM
MDEV
Healthcare
Financial Services
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
GERM
MDEV
Financial Services
GERM
MDEV
-
Basic Materials
GERM
-
MDEV
-
Communication Services
GERM
-
MDEV
-
Consumer Cyclical
GERM
-
MDEV
-
Consumer Defensive
GERM
-
MDEV
-
Energy
GERM
-
MDEV
-
Industrials
GERM
-
MDEV
-
Real Estate
GERM
-
MDEV
-
Technology
GERM
-
MDEV
-
Utilities
GERM
-
MDEV
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GERM vs. MDEV — Risk / Return Rank
GERM
MDEV
GERM vs. MDEV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and First Trust Indxx Medical Devices ETF (MDEV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| GERM | MDEV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | -0.44 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | — | -0.32 | — |
Drawdowns
GERM vs. MDEV - Drawdown Comparison
The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum MDEV drawdown of -42.34%. Use the drawdown chart below to compare losses from any high point for GERM and MDEV.
Loading charts...
Drawdown Indicators
| GERM | MDEV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | -42.34% | +42.34% |
Max Drawdown (1Y)Largest decline over 1 year | 0.00% | -18.13% | +18.13% |
Max Drawdown (3Y)Largest decline over 3 years | — | -22.50% | — |
Current DrawdownCurrent decline from peak | 0.00% | -33.76% | +33.76% |
Average DrawdownAverage peak-to-trough decline | 0.00% | -25.65% | +25.65% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.00% | 7.22% | -7.22% |
Volatility
GERM vs. MDEV - Volatility Comparison
The current volatility for Amplify Treatments, Testing and Advancements ETF (GERM) is 0.00%, while First Trust Indxx Medical Devices ETF (MDEV) has a volatility of 4.60%. This indicates that GERM experiences smaller price fluctuations and is considered to be less risky than MDEV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GERM | MDEV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.00% | 4.60% | -4.60% |
Volatility (6M)Calculated over the trailing 6-month period | 0.00% | 11.42% | -11.42% |
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | 16.00% | -16.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.00% | 18.98% | -18.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.00% | 18.98% | -18.98% |
GERM vs. MDEV - Expense Ratio Comparison
GERM has a 0.68% expense ratio, which is lower than MDEV's 0.70% expense ratio.
Dividends
GERM vs. MDEV - Dividend Comparison
Neither GERM nor MDEV has paid dividends to shareholders.
Frequently Asked Questions
MDEV has higher volatility (4.60%) compared to GERM (0.00%). In terms of maximum drawdown, GERM dropped 0.00% vs MDEV's -42.34%.
On 1-year performance, GERM leads with 0.00% vs -7.05% for MDEV. On fees, GERM is cheaper at 0.68% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, GERM has performed better with a 0.00% return vs -7.05%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
GERM is cheaper with a 0.68% expense ratio, compared with 0.70% for MDEV.
GERM and MDEV have nearly identical dividend yields, around 0.00%.
GERM tracks Prime Treatments, Testing and Advancements Index, while MDEV tracks Indxx Global Medical Equipment Index. They also come from different issuers: Amplify and First Trust. Their fees differ too: 0.68% for GERM and 0.70% for MDEV.
Find the right allocation for GERM and MDEV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer